Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12176261rdf:typepubmed:Citationlld:pubmed
pubmed-article:12176261lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:12176261lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:12176261lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:12176261lifeskim:mentionsumls-concept:C0205223lld:lifeskim
pubmed-article:12176261lifeskim:mentionsumls-concept:C0102137lld:lifeskim
pubmed-article:12176261lifeskim:mentionsumls-concept:C0991566lld:lifeskim
pubmed-article:12176261pubmed:issue1-2lld:pubmed
pubmed-article:12176261pubmed:dateCreated2002-8-14lld:pubmed
pubmed-article:12176261pubmed:abstractTextAlginate beads containing 5-fluorouracil (5-FU) were prepared by the gelation of alginate with calcium cations. Alginate beads loaded with 5-FU were prepared at 1.0 and 2.0% (w/v) polymers. The effect of polymer concentration and the drug loading (1.0, 5.0 and 10%) on the release profile of 5-FU was investigated. As the drug load increased, larger beads were obtained in which the resultant beads contained higher 5-FU content. The encapsulation efficiencies obtained for 5-FU loads of 1.0, 5.0 and 10% (w/v) were 3.5, 7.4 and 10%, respectively. Scanning electron microscopy (SEM) and particle size analysis revealed differences between the formulations as to their appearance and size distribution. The amount of 5-FU released from the alginate beads increased with decreasing alginate concentrations.lld:pubmed
pubmed-article:12176261pubmed:languageenglld:pubmed
pubmed-article:12176261pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12176261pubmed:citationSubsetIMlld:pubmed
pubmed-article:12176261pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12176261pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12176261pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12176261pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12176261pubmed:statusMEDLINElld:pubmed
pubmed-article:12176261pubmed:monthAuglld:pubmed
pubmed-article:12176261pubmed:issn0378-5173lld:pubmed
pubmed-article:12176261pubmed:authorpubmed-author:KimNNlld:pubmed
pubmed-article:12176261pubmed:authorpubmed-author:SargonMMlld:pubmed
pubmed-article:12176261pubmed:authorpubmed-author:Cali?SSlld:pubmed
pubmed-article:12176261pubmed:authorpubmed-author:HincalAAlld:pubmed
pubmed-article:12176261pubmed:authorpubmed-author:AricaBBlld:pubmed
pubmed-article:12176261pubmed:issnTypePrintlld:pubmed
pubmed-article:12176261pubmed:day21lld:pubmed
pubmed-article:12176261pubmed:volume242lld:pubmed
pubmed-article:12176261pubmed:ownerNLMlld:pubmed
pubmed-article:12176261pubmed:authorsCompleteYlld:pubmed
pubmed-article:12176261pubmed:pagination267-9lld:pubmed
pubmed-article:12176261pubmed:meshHeadingpubmed-meshheading:12176261...lld:pubmed
pubmed-article:12176261pubmed:meshHeadingpubmed-meshheading:12176261...lld:pubmed
pubmed-article:12176261pubmed:meshHeadingpubmed-meshheading:12176261...lld:pubmed
pubmed-article:12176261pubmed:meshHeadingpubmed-meshheading:12176261...lld:pubmed
pubmed-article:12176261pubmed:meshHeadingpubmed-meshheading:12176261...lld:pubmed
pubmed-article:12176261pubmed:meshHeadingpubmed-meshheading:12176261...lld:pubmed
pubmed-article:12176261pubmed:meshHeadingpubmed-meshheading:12176261...lld:pubmed
pubmed-article:12176261pubmed:meshHeadingpubmed-meshheading:12176261...lld:pubmed
pubmed-article:12176261pubmed:meshHeadingpubmed-meshheading:12176261...lld:pubmed
pubmed-article:12176261pubmed:meshHeadingpubmed-meshheading:12176261...lld:pubmed
pubmed-article:12176261pubmed:year2002lld:pubmed
pubmed-article:12176261pubmed:articleTitle5-Fluorouracil encapsulated alginate beads for the treatment of breast cancer.lld:pubmed
pubmed-article:12176261pubmed:affiliationDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, 06100 Sihhiye-Ankara, Turkey.lld:pubmed
pubmed-article:12176261pubmed:publicationTypeJournal Articlelld:pubmed